BRIEF: China Traditional Chinese Medicine’s profit tumbles in 2024

0570.HK

China Traditional Chinese Medicine Holdings Co. Ltd. (0570.HK) on Wednesday warned that it expects to report its profit for all of 2024 fell by 90% to 100%, while its adjusted profit also fell by 50% to 60% year-on-year.

The company’s profit totaled 1.4 billion yuan ($191 million) in 2023, according to its latest annual report, meaning last year’s profit will fall to 140 million yuan or even to nil.

The company blamed the big drop on price cuts required by China’s centralized procurement system, as well as intensifying market competition and relatively high costs of medicinal materials. It added that credit, goodwill and plant impairment costs increased during the period. Its profit was also affected by remedial taxes on some of its subsidiaries last year.

Shares of China Traditional Chinese Medicine fell 6.3% to HK$1.92 in Thursday trading after the profit warning’s release.

By Lau Chi HangTo subscribe to Bamboo Works weekly free newsletter, click  here

,
, ,

Related Articles

RELATED ARTICLES

  1. TCMTech’s biggest selling point, about to unleash its potential
    TCMTech fuses old with the new by mixing AI and Chinese medicine
  2. Yan Palace flies back to profit growth as revenue sags
    1497.HK
  3. Xiabuxiabu gets chilled by China’s weak economy
    0520.HK
  4. Imax China roars into Year of the Snake after weak performance in 2024
    1970.HK
  5. After profit plunge in 2024, Maoyan spotlights strong start to 2025
    1896.HK
  6. BRIEF: China Hongqiao profit nearly doubles in 2024
    1378.HK
  7. Gasping Huabao’s profits go up in smoke
    0336.HK 300741.SHE
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

Illustration of the rebound of Chinese fintech lenders

A fintech lender rebound, and a hotel mess

Fintech lenders are entering a new golden era, with Jiayin reporting 46% growth for its core consumer lending business in last year's fourth quarter and forecasting similar gains this year. What's driving this rebound? And hotelier H World is still trying to fix a German acquisition from 2019 that wiped out its profit in the fourth quarter of last year. Will the Chinese hotelier be able to turn around this money-losing offshore asset?
JFIN.US HTHT.US